The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth

Kimberley Hanson(University of East Anglia), Grant N. Wheeler(University of East Anglia), Karamallah Al‐Yousuf(University of East Anglia), Adam E. Hendry(University of East Anglia), Victoria Sherwood(Ninewells Hospital), Stephen D. Robinson(University of East Anglia), Darren W. Sexton(Liverpool John Moores University)
Oncotarget
December 17, 2017
Cited by 29


Related Papers